Stock Tickers: MU, RIMM, YHOO, MCHP, MRVL, CLMS, BEN, BOW, JNS, LM, HBAN, GILD, OSIP, BIIB, MEDI, JNC, CNS, FII, GBL, AB, BLK
This is one of the last research summaries that Goldman Sachs will be issuing before the earnings deluge comes.
The first and foremost call was a Downgrade on Micron (MU) to a Sell from a neutral. MU is still up pre-market after wider losses, but it was up much more last night. It sees 17% downside to the stock.
Goldman is making a switch in its investment manager coverage: It hasraised Janus (JNS) from Sell to Neutral, and downgraded Calamos (CLMS)from a Neutral down to a Sell.
Some of its INCREASED earnings estimates are on the following: Gilead(GILD), OSI Pharma (OSIP), Packaging Corp of America (PKG), Research inMotiuon (RIMM), Smurfit-Stone Container (SSCC), Yahoo! (YHOO).
Some of Goldman’s DECREASED earnings estimates are in the following:Affiliated Managers Group (AMG), AllianceBernstein (AB), Biogen-Idec(BIIB), BlackRock (BLK), Calamos (CLMS), Bowater (BOW), Cohen &Steers (CNS), Federated Investors (FII), Franklin Resources (BEN),GAMCO Investors (GBL), Legg Mason (LM), Huntington Bancshares (HBAN),MedImmune (MEDI), T. Rowe PRice (TROW), ViroPharma (VPHM), Waddell& Reed (WDR), Nuveen (JNC), Eaton Vance (EV).
Yahoo! (YHOO) estimates were raised by 2% revenues and 3% EBITDArespectively for 2007; price target raised from $31.50 to $35.00.
Maintained buy and positive ratings on Marvell Tech (MRVL), BEA Systems(BEAS), and Research in Motion (RIMM). On Micrchip Tech (MCHP) Goldmansaid it has some positive takeaways from the company’s competitors andcustomers, but it is not yet making any changes to its Neutral ratings.
Jon C. Ogg
April 5, 2007
Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.